Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 15, 2018
Accession Number: 0001104659-18-016500
Submission Type: POS AM
CIK: 0001634432
Company Name: Strongbridge Biopharma plc
File Number: 333-217555